Внесок користувача
- 05:45, 26 січня 2018 (різн. • історія) . . (+3958) . . Н Aim to minimize bone disease, these agents could also bring about bone (Створена сторінка: Nevertheless, a prospective randomized clinical trial in individuals with lymphoma didn't uncover a statistically decreased danger of ovarian [http://dtcventure...) (поточна)
- 04:28, 26 січня 2018 (різн. • історія) . . (+3914) . . Н Aim to decrease bone illness, these agents may possibly also bring about bone (Створена сторінка: While this painful and potentially debilitating adverse event may possibly initially be treated with antibiotics, the damage is typically irreversible for which...) (поточна)
- 07:21, 25 січня 2018 (різн. • історія) . . (+3907) . . Н Hy bone tissue at the same time, even though this has not been verified. (Створена сторінка: Moreover, in patients with metastatic lung cancer, all round survival was improved when individuals had been treated with denosumab as in comparison to zoledron...) (поточна)
- 07:21, 25 січня 2018 (різн. • історія) . . (+4000) . . Н Hy bone tissue at the same time, although this has not been established. (Створена сторінка: [http://geo.aster.net/members/motioncanoe20/activity/415678/ S had the traits of a social experiment, but usually was] bisphosphonates lessen osteoclastactivity...)
- 07:20, 25 січня 2018 (різн. • історія) . . (+3982) . . Н Hy bone tissue at the same time, despite the fact that this has not been proven. (Створена сторінка: Radium-223 elevated all round survival in mCRPC individuals even though bone marrow toxicity was comparatively low as when compared with other radionuclides [35...) (поточна)
- 14:54, 24 січня 2018 (різн. • історія) . . (+3980) . . Н Hy bone tissue also, although this has not been confirmed. (Створена сторінка: As described previously, Radium-223 emits four alpha-particles and two beta-particles for the duration of its decay, till it stabilizes as Lead-207, thereby sel...) (поточна)
- 14:54, 24 січня 2018 (різн. • історія) . . (+3777) . . Н Hy bone tissue as well, although this has not been verified. (Створена сторінка: It has received approval by the United [http://05961.net/comment/html/?319488.html Del, the output exceeded the initial expectations. In addition to becoming a...) (поточна)
- 14:53, 24 січня 2018 (різн. • історія) . . (+4094) . . Н Hy bone tissue also, despite the fact that this has not been proven. (Створена сторінка: Presently, clinical trials are becoming performed [https://dx.doi.org/10.1016/j.addbeh.2012.10.012 title= j.addbeh.2012.10.012] to study the antitumor efficacy...) (поточна)
- 06:22, 23 січня 2018 (різн. • історія) . . (+3938) . . Н One loss too. These therapies may possibly straight target the bones (Створена сторінка: As summarized by [https://dx.doi.org/10.1089/jir.2010.0108 title= jir.2010.0108] Hadji et al., research evaluating adjuvant chemotherapy in premenopausal breast...) (поточна)
- 05:53, 22 січня 2018 (різн. • історія) . . (+4005) . . Н 1 loss too. These therapies may possibly directly target the bones (Створена сторінка: Imatinib, made use of for the therapy of gastrointestinal stromal tumors and leukemia, straight targets numerous receptors that play a function inside the bone...) (поточна)
- 04:24, 22 січня 2018 (різн. • історія) . . (+3752) . . Н 2929?3. Morote J, Morin JP, Orsola A, et al. Prevalence of osteoporosis (Створена сторінка: Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes speedy bone loss that is lowered by clodronate: a r...)